abstract |
The present invention relates to a pharmaceutical vaccine composition comprising at least one vaccine antigen together with living immune cells. Such immune cells comprise part of at least one activated T cell and serve as an adjuvant. Also included are methods for the prevention and treatment of diseases such as cancer, infectious diseases, and autoimmune diseases using such pharmaceutical compositions. |